Haemonetics Corporation HAE
NYSE
| 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.05% | -41.97% | 34.88% | 35.84% | 42.17% |
| Total Depreciation and Amortization | -4.18% | -3.00% | -0.48% | 6.56% | 14.56% |
| Total Amortization of Deferred Charges | -8.96% | -8.96% | -22.09% | -22.09% | -22.09% |
| Total Other Non-Cash Items | 315.58% | 25,456.64% | 116.59% | 154.52% | 39.18% |
| Change in Net Operating Assets | 115.07% | 76.80% | 117.14% | 84.45% | 23.06% |
| Cash from Operations | 44.85% | 61.35% | 162.16% | 240.27% | 67.51% |
| Capital Expenditure | 1.19% | 16.54% | -1.46% | 9.50% | -3.53% |
| Sale of Property, Plant, and Equipment | -58.75% | -94.09% | -84.55% | -85.45% | -85.36% |
| Cash Acquisitions | -3,329.06% | 60.12% | 100.00% | 100.00% | 99.55% |
| Divestitures | -- | -- | 2,786.07% | 2,786.07% | 2,786.07% |
| Other Investing Activities | -15.76% | -129.94% | -162.07% | -109.95% | -55.70% |
| Cash from Investing | -203.03% | -10.90% | 61.19% | 85.87% | 87.52% |
| Total Debt Issued | -- | -68.42% | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | -7,499.19% | 39.08% | 98.89% | 98.90% | 99.18% |
| Issuance of Common Stock | -4.64% | -5.28% | -4.68% | 0.05% | -3.07% |
| Repurchase of Common Stock | 22.39% | 23.48% | -169.76% | -171.40% | -1,527.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.13% | 99.91% | 99.90% | 99.77% | 99.80% |
| Cash from Financing | -0.10% | -264.00% | -216.08% | -175.15% | -161.03% |
| Foreign Exchange rate Adjustments | -127.03% | 605.55% | 213.53% | -101.07% | 286.07% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.90% | -147.92% | -66.48% | 94.48% | -187.77% |